<DOC>
	<DOCNO>NCT00510276</DOCNO>
	<brief_summary>This study evaluate atomoxetine 's efficacy treat attention-deficit/hyperactivity disorder ( ADHD ) symptoms atomoxetine 's effect functional outcome young adult . A gatekeeper strategy employ sequentially test secondary objective . This study also observational community sample arm patient complete efficacy measurement via web-based self reporting .</brief_summary>
	<brief_title>Treatment Attention-Deficit/Hyperactivity Disorder ( ADHD ) With Atomoxetine Young Adults Its Effects Functional Outcomes</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<criteria>positive attentiondeficit/hyperactivity disorder ( ADHD ) diagnosis least moderate severity male female 18 30 year age must able swallow capsule must able communicate effectively English must cognitive impairment reliable keep appointment clinic visit related test patient diagnose obsessivecompulsive disorder , bipolar affective disorder , psychosis female pregnant breastfeed patient dementia traumatic brain injury patient history severe allergy atomoxetine untreated hypertension thyroid problem serious medical illness include heart , liver , kidney , respiratory , blood , endocrine , neuromuscular disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>